ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT03477396

Public ClinicalTrials.gov record NCT03477396. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIA Trial Assessing the Tolerability of Ribociclib in Combination With an Aromatase Inhibitor in Patients Aged 70 and Older With Hormone Receptor Positive Metastatic Breast Cancer

Study identification

NCT ID
NCT03477396
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
City of Hope Medical Center
Other
Enrollment
2 participants

Conditions and interventions

Interventions

  • Aromatase Inhibitor Drug
  • Laboratory Biomarker Analysis Other
  • Pharmacokinetic Study Other
  • Questionnaire Administration Other
  • Ribociclib Drug

Drug · Other

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 13, 2018
Primary completion
Sep 28, 2021
Completion
Jun 4, 2023
Last update posted
Feb 19, 2024

2018 – 2023

United States locations

U.S. sites
9
U.S. states
2
U.S. cities
9
Facility City State ZIP Site status
City of Hope Corona Corona California 92879
City of Hope Medical Center Duarte California 91010
City of Hope Antelope Valley Lancaster California 93534
City of Hope Mission Hills Mission Hills California 91345
City of Hope Rancho Cucamonga Rancho Cucamonga California 91730
City of Hope South Pasadena South Pasadena California 91030
City of Hope West Covina West Covina California 91790
Roswell Park Cancer Institute Buffalo New York 14263
Wilmot Cancer Institute Rochester New York 14642

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03477396, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2024 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03477396 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →